Community Research and Development Information Service - CORDIS

Results 1 - 10 of 95
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > 
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
ID: 115749
Start date: 2015-01-01, End date: 2019-12-31
Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential to improve the development of personalized medicines for cancer patients. This is of particular importance when biopsies of the primary ...
Programme: FP7-JTI
Record Number: 203725
Last updated on: 2017-04-24
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
ID: 115565
Start date: 2014-02-01, End date: 2019-01-31
We concur to the IMI on “Reclassification of SLE, connective tissue diseases and RA” call by presenting a proposal aimed at using the power of OMICs, and bioinformatics to identify new classifications for diseases known to share common pathophysiological mechanisms. Such know...
Programme: FP7-JTI
Record Number: 203714
Last updated on: 2017-04-24
Applied Public-Private Research enabling OsteoArthritis Clinical Headway
ID: 115770
Start date: 2015-06-01, End date: 2020-11-30
The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharmaceutical companies have de-emphasized or even abandoned OA drug development due to perceived hurdles. Crucial in this is the lack of ap...
Programme: FP7-JTI
Record Number: 203727
Last updated on: 2017-04-17
Kinetics for Drug Discovery (K4DD)
ID: 115366
Start date: 2012-11-01, End date: 2017-10-31
There is mounting evidence that the often ignored kinetic aspects of the interaction between a drug and its target are highly relevant for clinical success. This ignorance may be one of the reasons for the high attrition rates in drug discovery, as it has been analyzed that m...
Programme: FP7-JTI
Record Number: 203705
Last updated on: 2017-04-17
Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries
ID: 115360
Start date: 2012-10-01, End date: 2017-06-30
CHEM21 is a project that will develop a broad based portfolio of sustainable technologies for green chemical intermediate manufacture aimed at the pharmaceutical industry. Initially working with the EFPIA members the collaborators of CHEM21 will analyse a number of projects t...
Programme: FP7-JTI
Record Number: 203703
Last updated on: 2017-04-17
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
ID: 115303
Start date: 2012-03-01, End date: 2017-11-30
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia...
Programme: FP7-JTI
Record Number: 203697
Last updated on: 2017-04-17
OncoTrack - Methods for systematic next generation oncology biomarker development
ID: 115234
Start date: 2011-01-01, End date: 2016-12-31
We propose here an exhaustive analysis of the genome, exome, methylome and transcriptome of primary tumours and metastases from patients with colon carcinoma, based on a combination of deep sequencing and chip based techniques. Dependent on their availability, we shall also p...
Programme: FP7-JTI
Record Number: 203695
Last updated on: 2017-04-17
The Open Pharmacological Concepts Triple Store
ID: 115191
Start date: 2011-03-01, End date: 2016-02-29
Drug discovery is data-hungry and all major pharmaceutical companies maintain extensive in-house instances of public data alongside internal. Analysis and hypothesis generation for drug-discovery projects requires assembly, overlay and comparison of data from many sources, re...
Programme: FP7-JTI
Record Number: 203694
Last updated on: 2017-04-17
BeTheCuRE
[PROJECT] BTCURE - BeTheCuRE
ID: 115142
Start date: 2011-04-01, End date: 2017-03-31
BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal models have to develop the line with the different subsets of the human diseases in order to be optimally used for drug discovery and drug ev...
Programme: FP7-JTI
Record Number: 203688
Last updated on: 2017-04-17
European Medicines Research Training Network
ID: 115015
Start date: 2009-10-01, End date: 2016-09-30
EMTRAIN is an essential element for the success of the IMI Education & Training (E&T) Call Topics in Europe (current and future). It will establish a pan-European platform of excellence for education and training covering the whole life-cycle of medicines from basic research ...
Programme: FP7-JTI
Record Number: 203687
Last updated on: 2017-04-17
12 3 4 5 6 7 8 9 10 > 
List retrieved on: 2017-04-28
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top